Global Regenerative MedicineMarket size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.
Developments in biotechnology have enabled gaining in-depth
knowledge pertaining to cell division and differentiation as well as the
metabolism mechanism of various cells. This enriched knowledge, coupled with
emergence of novel streams of biotechnology such as gene therapy and
nanotechnology, further prospered use of cell-based technology in therapeutic
treatment.
Well established regenerative approached for various
dermatological indications exists since ages. Technological advances introduced
scaffolds, matrices, and grafts engineered for faster regeneration and minimal
surgical procedure.
Identification of ability of stem cells to develop into
various different cell lines further propelled the advancements in regenerative
medicine. Frequent media exposure due to regulatory as well as ethical
controversies around embryonic stem cells has increased awareness among the
masses. This encouraged researchers to explore and develop other potential
fields for similar applications, such as induced pluripotent stem cells (iPSC).
Furthermore, the emergence of gene therapy techniques with
potential to rectify and restore effects of gene mutations in cells is under
development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as
well as mutations that induce degenerative characteristics are primarily
targeted.
Biologics, individually or in combination with cells or
devices, are explored to support regenerate the biological functions of cells,
tissues, or organs. A number of combinatorial therapies to support chemotherapy
and other cancer treatments by prevention as well as treatment for cancer
relapse are in development phases.
In addition, rising prevalence of complicated degenerative
disorders such as age-related macular degeneration, Alzheimer’s disease, and
Parkinson’s disease, especially in the aging population resulted in high
investments in R&D to develop therapeutic solutions.
Regenerative medicine grabs the attention of the healthcare
industry owing to its promising applications along with significant advances in
supportive fields including tissue engineering, stem cells, gene therapy, drug
discovery and nanotechnology. For instance, 3D printing over scaffold with stem
cells to restore structure as well as functional characteristics of biological
cells, tissues, and organs.
Full Research Report on Global Regenerative Medicine
Market Analysis:
Further key findings from the report suggest:
- The
global regenerative medicine demand exceeded USD 1.7 billion in 2016 and
is expected to grow at a considerable rate over the forecast period owing
to the presence of a strong looking product pipeline with anticipated commercialization
just around the corner
- Therapeutics
emerged as the largest product segment in 2016 as it has a relatively high
implementation and usage rate resulting in higher adoption
- Global
regenerative services demand for facilities such as tissue banks and
cellular engineering tools is expected to drive demand in the segment
- The
industry in Asia Pacific is projected to witness substantial growth over
the next decade owing to various developments across major economies with
increased focus of dominant players in emerging economies is attributive
to market growth. market.
- Key players
including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and
MiMedx are involved in complex technical cum financial partnerships with
larger players in an attempt to expedite R&D
View more reports of
this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research
has segmented the Global Regenerative Medicine Market on the basis of product,
therapeutic category, and region:
Regenerative Medicine Product Outlook (Revenue, USD
Million, 2014 - 2025)
- Therapeutics
& Devices
·
Primary Cell-bases therapeutics
§ Dermatology
§ Musculoskeletal
§ Surgical
§ Dental
§ Others
·
Stem Cell & Progenitor Cell-based
therapeutics
§ Autologous
§ Allogeneic
§ Others
·
Tools
·
Banks
·
Services
Regenerative Medicine Therapeutic Category Outlook
(Revenue, USD Million, 2014 - 2025)
- Dermatology
- Musculoskeletal
- Immunology
& Inflammation
- Oncology
- Cardiovascular
- Ophthalmology
- Others
Regenerative Medicine Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
View Blog On this research report by Grand View Research:
About Grand View Research
Grand View Research,
Inc. is a U.S. based market research and consulting company, registered in the
State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com